Concepedia

Pierre Dalloz

PD

Statistics

Publications

3

Citations

256

H-Index

3

Active since

2017

Affiliations

Inserm(Current)

Centre Jean Perrin

Centre Léon Bérard

Institut Gustave Roussy

Groupe d'Oncologie Radiothérapie Tête et Cou

Pierre Dalloz is an author at Inserm specializing in radiation oncology, cancer research, and cancer therapeutics.

Top concepts

Publications per year

2017–2024

3

Publications

3

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

, , +11

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report

J. Biau, Emmanuel Chautard, Ellen Schlichting et al. · Radiation Oncology · 2017 · 32 citations · Full text

Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

J. Guigay, Cécile Ortholan, Damien Vansteene et al. · The Lancet Healthy Longevity · 2024 · 10 citations · Full text

1–3 of 3